Submit a Biologics License Application to the FDA for full U.S. licensure of the vaccine
No public evidence found either way
AI-assessed · human review in progress Found and assessed by AI from the cited sources. Shown with its evidence; it is not counted in any Kept Score until confirmed.
- Announced
- 21 Dec 2020
- Due
- 31 Dec 2021
- Last checked
- 10 Oct 2026
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Moderna intends to submit a Biologics License Application for full U.S. licensure in 2021”
What we found
After 4 checks we found no clear public record either way, so this commitment is not counted as met or not met.
If you have a public source showing the outcome, please send it to us.
Commitment lineage
Every time the company restated this commitment. The original is never changed, and the outcome is always measured against version 1.
- Deadline drift +546 days
- 2 versions
-
Version 1 · original · stated 21 Dec 2020
Deadline 31 Dec 2021 (“in 2021”) · wording aspirational
-
Version 2 · stated 23 Feb 2023
Deadline 30 Jun 2023 (“in the first half of 2023”) · wording firm
“Company will file for regulatory approval for mRNA-1345, Moderna's investigational RSV vaccine for older adults, in the first half of 2023.”
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- Biologics License Application for full U.S. licensure
- Where
- United States
- Language
- Aspirational (“aims”, “intends”)
- In the company’s control
- High
- Specificity
- Medium
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model read the company's later filings and recorded the outcome with a quoted passage.
Not yet confirmed. Shown on the record, but it will not count in any score until it is confirmed. How verification works
Are you Moderna? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2020-MRNA-006156 · Corrections policy